We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Joins FDA in Cautioning Against Use of Ivermectin for COVID-19
EMA Joins FDA in Cautioning Against Use of Ivermectin for COVID-19
The European Medicines Agency (EMA) has advised against the use of Merck’s anti-parasitic drug Stromectol (ivermectin) for the prevention and treatment of COVID-19.